Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (41-50 of 376) with videos related to

Pageof 38
Sort By:
Current Opinion in Lipidology|November 5, 2013
Recent failures in antiatherosclerotic drug development: examples from the thyroxin receptor agonist, the secretory phospholipase A2 antagonist, and the acyl coenzyme A: cholesterol acyltransferase inhibitor programsRobert M Stoekenbroek, John J P Kastelein, G Kees Hovingh
Pharmaceutical Research|January 30, 2015
Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureusSebastian G Wicha, Martin G Kees, Janin Kuss, et al.
Der Anaesthesist|August 24, 2014
[Pharmacokinetics and pharmacodynamics of antibiotic therapy]S Beck, S G Wicha, C Kloft, et al.
Annals of Clinical Microbiology and Antimicrobials|November 7, 2015
Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patientsCathérine L Steinbach, Christoph Töpper, Thomas Adam, et al.
Current Opinion in Lipidology|October 11, 2023
Angiopoietin-like 3 inhibition and the liver: less is more?Reindert F Oostveen, G Kees Hovingh, Erik S G Stroes
Frontiers in Physiology|October 7, 2022
The potential of glucagon-like peptide-1 receptor agonists in heart failureFrederik Flindt Kreiner, G Kees Kornelis Hovingh, Bernt Johan von Scholten
BMC Anesthesiology|May 1, 2015
Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patientsThomas Steinke, Stefan Moritz, Stefanie Beck, et al.
Trends in Endocrinology and Metabolism: TEM|October 22, 2019
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?Daniela Stols-Gonçalves, G Kees Hovingh, Max Nieuwdorp, et al.
European Heart Journal|May 2, 2025
iCARE4CVD: an innovative European consortium aiming to improve personalized cardiovascular careHans-Peter Brunner-La Rocca, Dirk Müller-Wieland, G Kees Hovingh
Data in Brief|May 17, 2016
Retrospective analysis of cohort database: Phenotypic variability in a large dataset of patients confirmed to have homozygous familial hypercholesterolemiaFrederick J Raal, Barbara Sjouke, G Kees Hovingh, et al.
Pageof 38

Showing results (41-50 of 376) with videos related to

Sort By:
Pageof 38
Current Opinion in Lipidology|November 5, 2013
Recent failures in antiatherosclerotic drug development: examples from the thyroxin receptor agonist, the secretory phospholipase A2 antagonist, and the acyl coenzyme A: cholesterol acyltransferase inhibitor programsRobert M Stoekenbroek, John J P Kastelein, G Kees Hovingh
Pharmaceutical Research|January 30, 2015
Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureusSebastian G Wicha, Martin G Kees, Janin Kuss, et al.
Der Anaesthesist|August 24, 2014
[Pharmacokinetics and pharmacodynamics of antibiotic therapy]S Beck, S G Wicha, C Kloft, et al.
Annals of Clinical Microbiology and Antimicrobials|November 7, 2015
Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patientsCathérine L Steinbach, Christoph Töpper, Thomas Adam, et al.
Current Opinion in Lipidology|October 11, 2023
Angiopoietin-like 3 inhibition and the liver: less is more?Reindert F Oostveen, G Kees Hovingh, Erik S G Stroes
Frontiers in Physiology|October 7, 2022
The potential of glucagon-like peptide-1 receptor agonists in heart failureFrederik Flindt Kreiner, G Kees Kornelis Hovingh, Bernt Johan von Scholten
BMC Anesthesiology|May 1, 2015
Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patientsThomas Steinke, Stefan Moritz, Stefanie Beck, et al.
Trends in Endocrinology and Metabolism: TEM|October 22, 2019
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?Daniela Stols-Gonçalves, G Kees Hovingh, Max Nieuwdorp, et al.
European Heart Journal|May 2, 2025
iCARE4CVD: an innovative European consortium aiming to improve personalized cardiovascular careHans-Peter Brunner-La Rocca, Dirk Müller-Wieland, G Kees Hovingh
Data in Brief|May 17, 2016
Retrospective analysis of cohort database: Phenotypic variability in a large dataset of patients confirmed to have homozygous familial hypercholesterolemiaFrederick J Raal, Barbara Sjouke, G Kees Hovingh, et al.
Pageof 38